Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Behavioral Neurobiology of Psychedelic Drugs, Paperback / softback Book

Behavioral Neurobiology of Psychedelic Drugs Paperback / softback

Edited by Adam L. Halberstadt, Franz X. Vollenweider, David E. Nichols

Part of the Current Topics in Behavioral Neurosciences series

Paperback / softback

Description

This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs.

Examples of drugs within this group include LSD, psilocybin, and mescaline.

Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action.  Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level.

To the extent possible, contributions relate the clinical and preclinical findings to one another across species.

The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.

Information

£199.99

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Current Topics in Behavioral Neurosciences series  |  View all